Table of contents

Extended reports

• Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study (12 September, 2003)

  A-K Nilsdotter, I F Petersson, E M Roos, L S Lohmander
• Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients (12 September, 2003)

  J F Maillefert, A Gueguen, M Monreal, M Nguyen, L Berdah, M Lequesne, B Mazieres, E Vignon, M Dougados
• Comparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip (12 September, 2003)

  H L Hoeksma, C H M Van den Ende, H K Ronday, A Heering, F C Breedveld, J Dekker
• Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis (12 September, 2003)

  P Garnero, T Conrozier, S Christgau, P Mathieu, P D Delmas, E Vignon
• Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study (12 September, 2003)

  D Aletaha, T Stamm, T Kapral, G Eberl, J Grisar, K P Machold, J S Smolen
• Leptin consumption in the inflamed joints of patients with rheumatoid arthritis (12 September, 2003)

  M Bokarewa, D Bokarew, O Hultgren, A Tarkowski
• Detection of cases of inflammatory rheumatic disorders: performance of a telephone questionnaire designed for use by patient interviewers (12 September, 2003)

  F Guillemin, A Saraux, P Fardellone, P Guggenbuhl, J-M Behier, J Coste
• Salivary gland scintigraphy in Sjögren’s syndrome and patients with sicca symptoms but without Sjögren’s syndrome: the psychological profiles and predictors for salivary gland dysfunction (12 September, 2003)

  E-K Tensing, D C Nordström, S Solovieva, K-O Schauman, I Sippo-Tujunen, T Helve, S Natah, J Ma, T F Li, Y T Konttinen
• Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women (12 September, 2003)

  J A Stakkestad, L I Benevolenskaya, J J Stepan, A Skag, A Nordby, E Oefjord, A Burdeska, I Jonkanski, P Mahoney
• Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis (12 September, 2003)

  E Šimelyte, M Rimpiläinen, X Zhang, P Toivanen
• IFNγ deficient C57BL/6 (H-2^b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vβ6 and Vβ8 in arthritic joints

  (12 September, 2003)

  C-Q Chu, Z Song, L Mayton, B Wu, P H Wooley